Raltitrexed

What Raltitrexed Means in Everyday Medical Language

Raltitrexed, also known by the code name ICI D1694, is a medicine used in cancer care. It works by blocking an important enzyme called thymidylate synthase, which cancer cells need to make DNA. Since DNA is essential for cells to grow and divide, stopping this process helps slow or stop the growth of tumors. Raltitrexed belongs to a group of drugs called thymidylate synthase inhibitors, which target this specific step in cancer cell growth.

Why Raltitrexed Can Matter in Cancer Care

Drugs like raltitrexed are part of chemotherapy treatments designed to control cancer by interfering with how cancer cells multiply. Because cancer cells often grow faster than normal cells, blocking DNA production can help reduce tumor size or slow disease progression. Raltitrexed has been used especially in colorectal cancer and some other cancers. However, it is not approved for use in all countries, and whether it is right for a person depends on many factors including the type of cancer, stage, and overall health.

What Patients Might See or Hear About Raltitrexed

You might see the term ICI D1694 or raltitrexed in medical reports, visit notes, treatment plans, or educational materials about cancer. Sometimes the drug is referred to by its code name (ICI D1694) or its generic name (raltitrexed). Because these names refer to the same drug, it’s helpful to recognize both to avoid confusion. Seeing the name alone does not mean a diagnosis or that this drug will be used in treatment. It is simply the name of a medicine that might be part of a treatment plan.

What the Term Does Not Automatically Mean

Finding the term ICI D1694 or raltitrexed in your medical records or discussions does not by itself mean you have a specific diagnosis or that this drug will be part of your treatment. It is important not to assume that the presence of this term means a treatment decision has been made. Instead, it should be understood in the full context of your care.

Common Questions to Ask Your Care Team

If you come across the term ICI D1694 or raltitrexed, it’s a good idea to ask your healthcare team what it means for your specific situation. You might ask if this drug is part of your treatment, how it works, what side effects it might have, and whether there are other treatment options. Understanding how this drug fits into your care can help you feel more informed and involved in decisions.

How to Read the Term in Context

Because raltitrexed can appear under different names, always look at the full context where the term appears. For example, if it’s in a treatment plan, ask how it will be used. If it’s in a report, ask what it means for your diagnosis or prognosis. Avoid making assumptions based on the word alone.

Safety and Next Steps

This information is meant to help you understand cancer-related terms and is not a substitute for medical advice. If you see ICI D1694 or raltitrexed mentioned in your care, the safest next step is to talk with your healthcare team. They can explain what it means for you personally and help guide your treatment decisions.